Additionally, Figure 1(b) showed that AUROC of VEGF-C for differentiating ovarian cancer from health controls was 0.862 (95% CI, 0.794–0.931), which was higher than 0.853 (95% CI, 0.773–0.933) of CA125. This evidence concerns the gene VEGFC and ovarian carcinoma.